Revisions ZYUS Life Sciences Corporation

Equities

Delayed Toronto S.E. Other stock markets 09:30:00 2024-06-26 EDT			5-day change	1st Jan Change
1.05 ^CAD	+3.96%		+3.96%	+16.67%

06-04	ZYUS Life Sciences Corp. Brief: Says Cannabis Drug License Enables It to Expand its Clinical Research Activities by Manufacturing Drugs Containing Cannabis in Canada	MT
06-04	ZYUS Life Sciences Corp. Brief: Lost 4.6% on Monday, But Today Said It Received Cannabis Drug License from Health Canada	MT